Public Release:  American Heart Association conference highlights solutions for reducing sodium intake

Tate & Lyle

11 June 2014 - Sodium intake around the world continues to be of concern1 and public health authorities hypothesise that it may be linked with cardiovascular disease risk2. In an effort to identify ways to reduce the amount of sodium consumed and provided in the food supply, the American Heart Association brought together over 100 key stakeholders and thought leaders at a special conference in June 2013. Proceedings from the conference were published in the May 2014 edition of Circulation3.

Among the top priorities identified by the group were increasing consumer understanding for the need to reduce sodium intake and the use of food technologies to reduce sodium in the food supply as much as possible. In an effort to advance sodium reduction technology, Tate & Lyle showcased an ingredient at the conference, SODA-LO® Salt Microspheres, which has the potential to be a major contributor for reducing sodium in the marketplace.

According to the American Heart Association publication, new food technologies, like SODA-LO® Salt Microspheres, can lower the sodium content of foods and are one part of the solution for meeting public health recommendations3.

Sodium Reduction Innovation: SODA-LO® Salt Microspheres

SODA-LO® Salt Microspheres is a salt-reduction ingredient that tastes, functions, and may label* like salt because it is salt. It can reduce sodium by 25 to 50% in food applications such as bread and salty snacks. SODA-LO® is created using a patented technology that transforms standard salt crystals into free-flowing, hollow salt microspheres that efficiently deliver salty taste by maximising surface area relative to volume.

Research presented at the conference showed the potential impact of replacing salt with SODA-LO® on overall sodium intake. Using US National Health and Nutrition Examination Survey (NHANES) 2007-2010 data3, the potential usage of SODA-LO® in 953 foods allowing 20-30% sodium reduction was modelled assuming a 50 or 100% market penetration. Results of the dietary modelling demonstrated that sodium intakes could decrease by 4% to 9% across age, sex, and ethnic groups. This reduction is equivalent to 130 to 360 mg/day. SODA-LO® Salt Microspheres can serve as one solution to help decrease population sodium intake. While changing consumer palates for foods lower in sodium may require significant time4, interim technologies like SODA-LO® can provide an immediate solution for sodium intake reduction.

'Tate & Lyle, as a leader in sodium reduction technology, can offer food manufacturers a novel, great tasting ingredient that can be used in products that consumers will enjoy and continue to demand,' stated Mike Harrison, Senior Vice President of New Product Development at Tate & Lyle.

SODA-LO® Salt Microspheres is the result of Tate & Lyle's Open Innovation team that creates partnerships to bring the most exciting new food ingredient technologies to market. Through a license agreement with Eminate, a wholly owned subsidiary of the University of Nottingham, UK, Tate & Lyle has exclusive, worldwide rights for product development, manufacturing and commercialisation of the SODA-LO® Salt Microspheres technology.

*Labelling rules vary from country to country.

###

References:

1 Brown IJ, Tzoulaki I, Candeias V, Elliott P. Int J Epidemiol. 2009; 38:791.

2 Institute of Medicine. Sodium Intake in Populations: Assessment of Evidence. Washington, DC: The National Academies Press; 2013.

3 Antman EM, Appel LJ, Balentine D, et al. Circulation. 2014; 129: published online May 5, 2014.

4 Hooper L, Bartlett C, Davey SG, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev 2004.1:CD003656.

About Tate & Lyle

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development group. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2014, Tate & Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.